PPR (koyun keçi vebası) ve mavidil aşısının merinos ırkı koyunlarda eş zamanlı uygulanabilirliğinin araştırılması

Öz

Bulaşıcı hayvan hastalıklar arasında yer alan PPR ve Mavi dil, ciddi ekonomik kayıplara sebep olmalarından dolayı, Dünya Hayvan Sağlığı Örgütü (OIE) tarafından ihbarı zorunlu hastalıklar içinde yer almaktadır. PPR ve Mavi dil aşıları, her iki hastalığın birlikte görüldüğü ülkelerde yaygın olarak kullanılmaktadır. Bu çalışmada, PPR ve Mavi dil aşılarının aynı anda uygulanarak koyunlardaki antikor yanıtı üzerine etkilerinin incelenmesi amaçlanmıştır. Bu amaçla çalışmanın birinci basamağında, seçilen hayvanların aşılama öncesi kanları alınarak her iki hastalık yönünden araştırılmıştır. İkinci basamağında, tekli PPR aşısı grubu (Grup 1; genç kuzu n=10, yetişkin koyun n=10), tekli BT-4 aşısı grubu (Grup 2; genç kuzu n=10, yetişkin koyun n=10), PPR ve BT-4 ile eş zamanlı aşılı grup (Grup 3; genç kuzu n=10, yetişkin koyun n=10) ve aşısız kontrol grubu (Grup 4; genç kuzu n=5, yetişkin koyun n=5) olmak üzere 4 koyun grubu kullanılmıştır. Çalışmanın üçüncü basamağında, seçilen hayvanlardan nötralize antikorlar yönünden test edilmesi amacıyla 0. gün, 1., 3. ve 6. aylarda serum örnekleri toplanarak toplamda 280 adet serum numunesi PPR ve Mavi dil antikorları virus nötralizasyon testi ile nötralizan antikorlar yönünden kontrol edilmiştir. Gruplar arasında nötralizan antikor seviyeleri kıyaslandığında grup 3’ün 1. ve 2. gruplardan istatistiksel olarak anlamlı bir fark (p >0.05) göstermediği görülmüştür. Çalışma sonucunda, PPR ve Mavidil aşılarının eş zamanlı olarak uygulanabileceği, iş gücü ve ekonomik açıdan tasarruf sağlayacağı tespit edilmiştir.

Anahtar Kelimeler

• Aşı
• BTV
• PPRV
• bağışıklık

INVESTIGATION OF SIMULTANEOUS ADMINISTRATION OF PPR (PESTE DES PETITS RUMINANTS) AND BLUETONGUE VACCINES IN MERINO SHEEP

Öz

Abstract: Peste des Petits Ruminants (PPR) and Bluetongue (BT), which are among the contagious animal diseases, cause serious economic losses and are included in the notifiable diseases by the World Organization for Animal Health (WOAH). PPR and BT vaccines are widely used in countries where outbreaks occur. In this study, we aimed to examine the neutralizing antibody response of simultaneously administered PPR and BT serotype 4 vaccines in sheep. For this purpose, a study was performed under field conditions in a state-owned breeding farm. All the experimental animals were confirmed seronegative by serum neutralization test (SNT) for antibodies to the PPR virus (PPRV) and BT virus serotype 4 (BTV4). Subsequently, the experimental animals were divided into four groups. Group 1 (Group 1/PPR; lamb n=10, sheep n=10) and group 2 (Group 2/BTV4; lamb n=10, sheep n=10) were vaccinated separately with the PPR and BTV4 vaccines. Group 3 was vaccinated simultaneously with PPR and BTV4 (Group 3/PPR-BTV4; lamb n=10, sheep n=10). Group 4 was unvaccinated and served as the control. In each of the experimental groups, the vaccinations were carried out only once. Post-vaccination blood samples were collected at intervals of 1, 3, and 6 months. A total of 280 post-vaccination blood serum samples were evaluated with SNT for PPRV and BTV4 neutralizing antibodies. When the neutralizing antibody levels between the groups were compared, group 3 did not show any statistically significant difference (p>0.05) from group 1 and group 2. Based on the antibody response of simultaneous vaccination, it is shown that the simultaneous vaccination could be administered on the field, and could be labor and cost-effective.

Anahtar Kelimeler

• BTV
• PPRV
• immunity
• simultaneous administration

Kaynakça

1. Jeggo MH, Wardley RC, and Brownlie J. (1984). “A study of the role of cell-mediated ımmunity in Bluetongue virus ınfection in sheep, using cellular adoptive transfer techniques.” Immunology 52(3):403–10.
2. Huismans H, Van Der Walt NT, Cloete M, and. Erasmus BJ. (1987). “Isolation of a capsid protein of Bluetongue virus that ınduces a protective ımmune response in sheep.” Virology 157(1):172–79. doi: 10.1016/0042-6822(87)90326-6.
3. Diallo A, G. LibeauE, Couacy-Hymann and Barbron M. (1995). “Recent Developments in the Diagnosis of Rinderpest and Peste Des Petits Ruminants.” Veterinary Microbiology 44(2–4):307–17. doi: 10.1016/0378-1135(95)00025-6.
4. Tatar N, and Kabaklı Ö. (2006). “Türkiye’de üretilen PPR aşısının bağışıklık süresinin tespiti.” Etlik Vet. Mikrobiyoloji 17:13–22.
5. Maan S, Maan NS,. Samuel AR, Rao S, Attoui H, and Peter P, Mertens C. (2007). “analysis and phylogenetic comparisons of full-length VP2 Genes of the 24 Bluetongue virus serotypes.” Journal of General Virology 88(2):621–30. doi: 10.1099/vir.0.82456-0.
6. Schwartz-cornil I, Mertens P, Contreras V, Hemati B, Pascale F, Emmanuel Br, Mellor P, Maclachlan N, Peter P. C. Mertens, Contreras V, Mellor PS, Maclachlan NJ, and Zientara S. (2008). “Bluetongue virus : virology , pathogenesis and ımmunity. Ephan Zientara To Cite This Version : Review Article.” in Vet. Res. Vol. 39.
7. SaravananP, Sen A, Balamurugan V, Rajak KK, Bhanuprakash V, Palaniswami KS, Nachimuthu K, Thangavelu A, Dhinakarraj G, Hegde R and Singh RK. (2010). “Comparative efficacy of Peste Des Petits Ruminants (PPR) vaccines.” Biologicals 38(4):479–85. doi: 10.1016/j.biologicals.2010.02.003.
8. Bréard E, Belbis G, Hamers C, Moulin V, Lilin T, Moreau F, Millemann Y, Montange C, Sailleau C, Durand B, Desprat A, Viarouge C, Hoffmann B, De Smit H, Goutebroze S, Hudelet P and Zientara S. (2011). “Evaluation of humoral response and protective efficacy of two ınactivated vaccines against bluetongue virus after vaccination of goats.” Vaccine 29(13):2495–2502. doi: 10.1016/j.vaccine.2010.12.105.

9. Rojas R, Manuel J, Rodríguez-Calvo T, Peña L, and Sevilla N. (2011). “T cell responses to Bluetongue virus are directed against multiple and ıdentical CD4 + and CD8 + T cell epitopes from the vp7 core protein in mouse and sheep.” Vaccine 29(40):6848–57. doi: 10.1016/j.vaccine.2011.07.061.
10. Balamurugan VA, Sen G, Venkatesan V, Bhanuprakash and Singh RK. (2014). “Protective ımmune response of live attenuated thermo-adapted peste des petits ruminants vaccine in goats.” VirusDisease 25(3):350–57. doi: 10.1007/s13337-014-0208-x.
11. Caporale M, Gialleonorado LD, Janowicz A, Wilkie G, Shaw A, Savini G, Piet A. Rijn V, Mertens P, Di Ventura M, and Palmarini M. (2014). “Virus and host factors affecting the clinical outcome of Bluetongue virus ınfection.” Journal of Virology 88(18):10399–411. doi: 10.1128/jvi.01641-14.
12. Mohd F, Belhouchet M, Vitour D, Adam M, Breard E, Zientara S, Mertens PPC and Attoui H. (2014). “Immunisation with bacterial expressed VP2 and VP5 of bluetongue mice from homologous lethal challenge.” Vaccine 32(32):4059–67. doi: 10.1016/j.vaccine.2014.05.056.
13. Sánchez-Cordón PJ, Pérez de Diego AC, Gómez-Villamandos JC, Sánchez-Vizcaíno JM, Pleguezuelos FJ, Garfia B, del Carmen P and Pedrera M. (2015). “Comparative analysis of cellular ımmune responses and cytokine levels in sheep experimentally ınfected with bluetongue virus serotype 1 and 8.” Veterinary Microbiology 177(1–2):95–105. doi: 10.1016/j.vetmic.2015.02.022.
14. Baron MD, Diallo A, Lancelot R and Libeau G. (2016). Peste Des Petits Ruminants Virus. Vol. 95. 1st ed. Elsevier Inc. Belbis G, Zientara S, Bréard E, Sailleau C, Caignard G, Vitour D, and Attoui H. (2017). “Bluetongue virus: From BTV-1 to BTV-27.” Pp. 161–97 in Advances in Virus Research. Vol. 99. Academic Press Inc.
15. Mohamed A and Özkul A Prof. D. (2019). “Koyun sürüleri̇nde PPR vi̇rus aşılaması sonrası sıvısal bağışık yanıtın değerlendi̇ri̇lmesi̇.”
16. Bamouh Z, Fakri F, Jazouli M, Safini N, Omari Tadlaoui K and Elharrak M. (2019). “Peste Des Petits Ruminants pathogenesis on experimental ınfected goats by the Moroccan 2015 Isolate.” BMC Veterinary Research 15(1):1–8. doi: 10.1186/s12917-019-2164-6.
17. Bitew M, Ravishankar C, Chakravarti S, Sharma GK, and Nandi S. (2019). “Comparative evaluation of T-Cell ımmune response to BTV ınfection in sheep vaccinated with pentavalent BTV vaccine when compared to un-vaccinated animals.” Veterinary Medicine International. doi: 10.1155/2019/8762780.
18. Chambaro HM, Sasaki M, Simulundu E, Silwamba I, Sinkala Y, Gonzalez G, Squarre D, Fandamu P, Lubaba CH, Munyeme M, Maseko A, Chimvwele C, Mataa L, Mooya LE, Mukubesa AN, Harima H, Samui KL, Munang’andu HM, Simuunza M, Nalubamba KS, Qiu Y, Carr MJ, Hall WW, Eshita Y, Sawa H, and Orba Y. (2020). “Co-circulation of multiple serotypes of Bluetongue Virus in Zambia.” Viruses 12(9):1–12. doi: 10.3390/v12090963.
19. Collins CA, Gelinas L, Yasukawa LL, Audet S, Abu-Raya B, Turvey SE, Beeler JA, Kollmann TR, and Gans HA. (2020). “Measles maternal antibodies with low avidity do not ınterfere with the establishment of robust quantity and quality antibody responses after the primary dose of measles, mumps, and rubella vaccine administered at 12-months of age.” Journal of the Pediatric Infectious Diseases Society 9(6):752–55. doi: 10.1093/jpids/piz074. Peta M, Faith R, Sirdar MM, Bavel P, Mutowembwa PB, Visser N, Olowoyo J, Seheri M, and Heath L. (2021). “Evaluation of potency and duration of ımmunity elicited by a multivalent FMD vaccine for use in South Africa.” Frontiers in Veterinary Science 8(December):1–13. doi: 10.3389/fvets.2021.750223.
20. Ries C, Vögtlin A, Hüssy D, Jandt T, Gobet H, Hilbe M, Burgener C, Schweizer L, Häfliger-Speiser S, Beer M and Hoffmann B. (2021). “Putative novel atypical BTV serotype ‘36’ ıdentified in small ruminants in Switzerland.” Viruses 13(5):1–17. doi: 10.3390/v13050721.
21. Selvaraj M, Mahapatra M, and Parida S. (2021). “Exchange of C-terminal variable sequences within morbillivirus nucleocapsid protein are tolerated: development and evaluation of two marker (DİVA) vaccines (Sungri/96 Diva, Nigeria/75/1 Diva) against Ppr.” Viruses 13(11). doi: 10.3390/v13112320.
22. WOAH (World Organisation for Animal Health). (2021a). Bluetongue (Infection with Bluetongue Virus). WOAH (World Organisation for Animal Health). (2021b). “Peste Des Petits Ruminants (Infection with Small Ruminanat Morbillivirus).” OIE Terrestrial Manual.Chapter 3.8.9 1–16.
23. Eloiflin RJ, Grau-Roma L, Python S, Mehinagic K, Godel A, Libeau G, Summerfield A, Bataille A, and García-Nicolás O. (2022). “Comparative pathogenesis of peste des petits ruminants virus strains of difference virulence.” Veterinary Research 53(1):57. doi: 10.1186/s13567-022-01073-6.